Table 3 Demographic data and laboratory results of BS patients (n = 251)
Variables | Intestinal BS (n = 97) | Mucocutaneous BS (n = 154) | P |
|---|---|---|---|
Demographic variables | |||
Gender (male), n (%) | 48 (49.48) | 45 (29.22) | 0.00* |
Age at hospitalization, (years) | 34.25 ± 13.14 | 37.84 ± 13.58 | 0.04* |
Age of disease onset, (years) | 26.68 ± 12.26 | 30.77 ± 12.17 | 0.01* |
Disease duration (years) | 7.27 ± 8.30 | 7.02 ± 7.08 | 0.80 |
BDCAF | 1.72 ± 0.87 | 1.16 ± 0.69 | 0.00* |
T-SPOT (+), n (%) | 22 (22.68) | 18 (11.69) | 0.02* |
Pathergy test (+), n (%) | 43 (44.33) | 54 (35.06) | 0.14 |
HBcAb (+), n (%) | 26 (26.80) | 41 (26.62) | 0.98 |
Fever, n (%) | 17 (17.53) | 9 (5.84) | 0.00* |
Laboratory parameters | |||
ESR (mm/H) | 35.08 ± 26.16 | 14.03 ± 14.75 | 0.00* |
CRP (mg/L) | 31.18 ± 29.94 | 7.48 ± 7.81 | 0.00* |
Erythrocyte (109/L) | 4.19 ± 0.65 | 4.34 ± 0.46 | 0.04* |
Leukocyte (109/L) | 7.03 ± 2.70 | 6.18 ± 2.17 | 0.01* |
PLT (109/L) | 244.37 ± 89.54 | 232.62 ± 67.48 | 0.27 |
HGB (g/L) | 121.21 ± 20.55 | 129.66 ± 14.61 | 0.00* |
NLR | 3.30 ± 2.73 | 2.13 ± 1.34 | 0.00* |
IgA (g/L) | 2.55 ± 1.18 | 2.72 ± 1.16 | 0.28 |
IgE (IU/ML) | 102.89 ± 325.37 | 61.82 ± 108.70 | 0.23 |
IgG (g/L) | 10.90 ± 3.19 | 11.38 ± 2.51 | 0.22 |
IgM (g/L) | 1.29 ± 0.70 | 1.24 ± 0.58 | 0.50 |
SAA (mg/L) | 69.60 ± 76.61 | 17.83 ± 31.37 | 0.00* |
C3 (g/L) | 1.26 ± 0.23 | 1.20 ± 0.19 | 0.03* |
C4 (g/L) | 0.25 ± 0.08 | 0.24 ± 0.07 | 0.32 |
CH50 (g/L) | 54.12 ± 10.55 | 53.58 ± 9.38 | 0.67 |
Albumin (g/L) | 41.86 ± 5.28 | 43.88 ± 5.13 | 0.00* |
TCH (mmol/L) | 4.03 ± 0.84 | 4.30 ± 1.06 | 0.03* |
TG (mmol/L) | 1.24 ± 0.58 | 1.23 ± 0.65 | 0.93 |
Glucose (mmol/L) | 4.79 ± 1.41 | 4.72 ± 0.69 | 0.58 |
UA (umol/L) | 267.63 ± 80.43 | 270.42 ± 71.61 | 0.78 |
LDL (mmol/L) | 2.26 ± 0.63 | 2.38 ± 0.69 | 0.17 |
HDL (mmol/L) | 1.34 ± 0.35 | 1.47 ± 0.34 | 0.00* |
IL-6 (pg/ml) | 13.46 ± 17.78 | 2.70 ± 3.87 | 0.00* |